Given that Dr. Ichim is among a select few that have already proven stem cell treatments work, I do not believe for one moment that the viability of the treatments are a question.

I truly believe the "delay" to be nothing more than the FDA requiring information over and above the standard requirement for IND application submission due to this being an Orphan Drug. And I believe the trials will be initiated very soon.